Bala Krishnan
- Organic Chemistry top 0.5%
- Chemical synthesis and alkaloids 4
- Toxicology top 1%
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis 9
- Biotechnology top 5%
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 5
- DNA and Nucleic Acid Chemistry 3
- Angiogenesis and VEGF in Cancer 3
-
- Metal complexes synthesis and properties 3
-
- Adipose Tissue and Metabolism 3
-
- Molecular spectroscopy and chirality 3
- Co-authors
- Vittorio FarinaTerrence W. DoyleJerzy GolikSuresh KapadiaLanny S. LiebeskindChenjie WangGeorge R. DubayMASATAKA KONISHI
- Journals
- Journal of the American Chemical Society (7 papers)The Journal of Organic Chemistry (5 papers)The Journal of Antibiotics (4 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Bala Krishnan
39 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Organic Chemistry 2.3k
- Toxicology 144
- Pharmacology 462
- Biotechnology 178
- Molecular Biology 1.2k
Countries citing papers authored by Bala Krishnan
This map shows the geographic impact of Bala Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bala Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bala Krishnan more than expected).
Fields of papers citing papers by Bala Krishnan
This network shows the impact of papers produced by Bala Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bala Krishnan. The network helps show where Bala Krishnan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bala Krishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2011 | 18 | |
| 3 | 2008 | 11 | |
| 4 | 2006 | 38 | |
| 5 | Preclinical studies of BMS-582664, an alanine prodrug of BMS-540215, a potent, dual inhibitor of VEGFR-2 and FGFR-1 kinases | 2005 | 1 |
| 6 | 2005 | 37 | |
| 7 | 1996 | 47 | |
| 8 | 1995 | 26 | |
| 9 | 1994 | 12 | |
| 10 | 1993 | 33 | |
| 11 | 1991 | 5 | |
| 12 | 1990 | 42 | |
| 13 | 1989 | 18 | |
| 14 | 1989 | 24 | |
| 15 | 1987 | 211 | |
| 16 | 1987 | 31 | |
| 17 | 1986 | 23 | |
| 18 | 1986 | 5 | |
| 19 | 1985 | 10 | |
| 20 | 1984 | 32 |
About Bala Krishnan
Bala Krishnan is a scholar working on Microbiology, Toxicology, Organic Chemistry, Pharmacology and Applied Microbiology and Biotechnology, having authored 39 papers that have together received 3.4k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (9 papers), Cancer therapeutics and mechanisms (5 papers), Chemical synthesis and alkaloids (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Metal complexes synthesis and properties (3 papers), Adipose Tissue and Metabolism (3 papers) and Molecular spectroscopy and chirality (3 papers). The work is most often cited by research in Organic Chemistry (2.3k citations), Toxicology (144 citations), Pharmacology (462 citations), Biotechnology (178 citations) and Molecular Biology (1.2k citations). Bala Krishnan has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Vittorio Farina, Terrence W. Doyle, Jerzy Golik, Suresh Kapadia, Lanny S. Liebeskind, Chenjie Wang, George R. Dubay, MASATAKA KONISHI, Jon Clardy and HIROAKI OHKUMA. Their work appears in journals such as Journal of the American Chemical Society, The Journal of Organic Chemistry, The Journal of Antibiotics, Tetrahedron Letters and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.